WallStreetZenWallStreetZen

NASDAQ: ASLN
Aslan Pharmaceuticals Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ASLN

Based on 2 analysts offering 12 month price targets for Aslan Pharmaceuticals Ltd.
Min Forecast
$3.00+3.09%
Avg Forecast
$11.50+295.19%
Max Forecast
$20.00+587.29%

Should I buy or sell ASLN stock?

Based on 2 analysts offering ratings for Aslan Pharmaceuticals Ltd.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ASLN stock forecasts and price targets.

ASLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 3%
3
BuyReiterates$20.00+587.29%2023-03-20
Piper Sandler
Bottom 5%
5
Strong BuyMaintains$3.00+3.09%2023-02-27

1 of 1

Forecast return on equity

Is ASLN forecast to generate an efficient return?
Company
N/A
Industry
-0.02%
Market
28.63%

Forecast return on assets

Is ASLN forecast to generate an efficient return on assets?
Company
N/A
Industry
0.05%

ASLN earnings per share forecast

What is ASLN's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.88
Avg 2 year Forecast
-$0.58
Avg 3 year Forecast
-$0.81

ASLN revenue forecast

What is ASLN's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$14.5M
Avg 2 year Forecast
$90.8M
Avg 3 year Forecast
$212.3M

ASLN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ASLN$2.91$11.50+295.19%Strong Buy
ABEO$2.71$23.00+748.71%Buy
GLTO$1.80$11.67+548.17%Strong Buy
MGTA$0.79$4.33+449.87%Strong Buy
PRTG$2.68$19.50+627.88%Buy
View Top Biotech Stocks

Aslan Pharmaceuticals Stock Forecast FAQ

Is Aslan Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ASLN) stock is to Strong Buy ASLN stock.

Out of 2 analysts, 1 (50%) are recommending ASLN as a Strong Buy, 1 (50%) are recommending ASLN as a Buy, 0 (0%) are recommending ASLN as a Hold, 0 (0%) are recommending ASLN as a Sell, and 0 (0%) are recommending ASLN as a Strong Sell.

If you're new to stock investing, here's how to buy Aslan Pharmaceuticals stock.

What is ASLN's earnings growth forecast for 2023-2025?

(NASDAQ: ASLN) Aslan Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.41%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.51%.

Aslan Pharmaceuticals's earnings in 2023 is -$51,382,417.On average, 3 Wall Street analysts forecast ASLN's earnings for 2023 to be -$353,862,815, with the lowest ASLN earnings forecast at -$554,921,232, and the highest ASLN earnings forecast at -$201,058,418. On average, 1 Wall Street analyst forecast ASLN's earnings for 2024 to be -$233,227,764, with the lowest ASLN earnings forecast at -$233,227,764, and the highest ASLN earnings forecast at -$233,227,764.

In 2025, ASLN is forecast to generate -$325,714,636 in earnings, with the lowest earnings forecast at -$325,714,636 and the highest earnings forecast at -$325,714,636.

What is ASLN's revenue growth forecast for 2025-2027?

(NASDAQ: ASLN) Aslan Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 40.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.77%.

Aslan Pharmaceuticals's revenue in 2023 is $0.On average, 1 Wall Street analysts forecast ASLN's revenue for 2025 to be $5,830,694,108, with the lowest ASLN revenue forecast at $5,830,694,108, and the highest ASLN revenue forecast at $5,830,694,108. On average, 1 Wall Street analysts forecast ASLN's revenue for 2026 to be $36,504,166,281, with the lowest ASLN revenue forecast at $36,504,166,281, and the highest ASLN revenue forecast at $36,504,166,281.

In 2027, ASLN is forecast to generate $85,357,340,565 in revenue, with the lowest revenue forecast at $85,357,340,565 and the highest revenue forecast at $85,357,340,565.

What is ASLN's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ASLN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.05%.

What is ASLN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ASLN price target, the average ASLN price target is $11.50, with the highest ASLN stock price forecast at $20.00 and the lowest ASLN stock price forecast at $3.00.

On average, Wall Street analysts predict that Aslan Pharmaceuticals's share price could reach $11.50 by Mar 20, 2024. The average Aslan Pharmaceuticals stock price prediction forecasts a potential upside of 295.19% from the current ASLN share price of $2.91.

What is ASLN's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: ASLN) Aslan Pharmaceuticals's current Earnings Per Share (EPS) is -$3.75. On average, analysts forecast that ASLN's EPS will be -$0.88 for 2023, with the lowest EPS forecast at -$1.38, and the highest EPS forecast at -$0.50. On average, analysts forecast that ASLN's EPS will be -$0.58 for 2024, with the lowest EPS forecast at -$0.58, and the highest EPS forecast at -$0.58. In 2025, ASLN's EPS is forecast to hit -$0.81 (min: -$0.81, max: -$0.81).

What is ASLN's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ASLN) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.